HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Unusual presentation of early lymphogranuloma venereum in an HIV-1 infected patient: effective treatment with 1 g azithromycin.

Abstract
The incidence of lymphogranuloma venereum (LGV) is low in the western world. Early LGV is characterised by bubonic disease following a painless papule or small ulcer. We report a white bisexual male who presented with a painful perianal ulcer, inguinal lymphadenitis, and concomitant infection with human immunodeficiency virus 1 (HIV-1). Chlamydia trachomatis serovar L2 was identified as the cause after polymerase chain reaction and genotyping the major outer membrane protein by restricted fragment length polymorphism. Treatment with a single dose of 1 g azithromycin was effective. This case illustrates that early LGV may mimic other genital ulcer diseases, such as genital herpes or chancroid, especially in HIV infected patients. In the western world, LGV must still be included in the differential diagnosis of bubonic disease with or without sexually acquired ulcers.
AuthorsR F Nieuwenhuis, J M Ossewaarde, W I van der Meijden, H A M Neumann
JournalSexually transmitted infections (Sex Transm Infect) Vol. 79 Issue 6 Pg. 453-5 (Dec 2003) ISSN: 1368-4973 [Print] England
PMID14663119 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Azithromycin
Topics
  • AIDS-Related Opportunistic Infections (complications)
  • Adult
  • Anti-Bacterial Agents (administration & dosage)
  • Anus Diseases (drug therapy, microbiology)
  • Azithromycin (administration & dosage)
  • Chlamydia trachomatis (isolation & purification)
  • Groin
  • HIV Infections (complications)
  • HIV-1
  • Humans
  • Lymphadenitis (microbiology)
  • Lymphogranuloma Venereum (complications, drug therapy)
  • Male
  • Ulcer (drug therapy, microbiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: